Teva's business is encountering headwinds, including declining U.S. generics revenue. Read what this biotech plans to do in ...

Cite this: What's Next? Clinical Trials in Myelofibrosis - Medscape - Mar 06, 2025.

Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in patients with multiple myeloma.

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

Pharma major, Biocon Pharma, has received final approvals from the U.S. Food and Drug Administration (FDA) for its ...

The rise in Biocon share price came after the company announced that its wholly-owned subsidiary, Biocon Pharma, has received ...

Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, ...

Biocon Pharma has received US FDA approvals for Lenalidomide capsules and Dasatinib tablets, with tentative approval for Rivaroxaban tablets. Coforge has partnered with Sabre Corporation to accelerate ...

Shares of firms like Adani Wilmar, Ola Electric, Ambuja Cements, ONGC, RVNL, and others will be in focus on Wednesday's trade ...